CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis. (NordCAN)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03693833|
Recruitment Status : Recruiting
First Posted : October 3, 2018
Last Update Posted : January 24, 2019
|Condition or disease||Intervention/treatment||Phase|
|Psoriatic Arthritis Hand Osteoarthritis||Drug: Cannabidiol Drug: Placebo Oral Tablet||Phase 2|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||180 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis. A Randomized, Double-blind Placebo Controlled Study|
|Actual Study Start Date :||October 20, 2018|
|Estimated Primary Completion Date :||October 1, 2019|
|Estimated Study Completion Date :||December 31, 2019|
10mg Cannabidiol (CBD) tablets once daily for the first two weeks increasing to twice daily for week 3 and 4 if adequate analgesic effect is not attained at week 5 then the dose can be increased to 10mg thrice daily from week 5 and onward.
Cannabidiol (CBD) tablets of 10mg each
Other Name: CBD
Placebo Comparator: Placebo
10mg Placebo Oral tablets once daily for the first two weeks increasing to twice daily for week 3 and 4 if adequate analgesic effect is not attained at week 5 then the dose can be increased to 10mg thrice daily from week 5 and onward.
Drug: Placebo Oral Tablet
Oral Placebo tablets of 10mg each
Other Name: Oral Placebo
- VAS pain during the last 24 hours [ Time Frame: Change from baseline to 12 weeks ]Measure with a 100mm Visual Analogue Scale (VAS) with higher values indicating more pain.
- VAS pain during the last 24 hours [ Time Frame: Change from 12 to 24 weeks ]Measure with a 100mm Visual Analogue Scale (VAS) with higher values indicating more pain.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03693833
|Contact: Jonathan Vela||976664018 ext +firstname.lastname@example.org|
|Department of Rheumatology Aalborg Universityhospital North||Recruiting|
|Aalborg, Denmark, 9000|
|Contact: Jonathan Vela, MD 97664018 ext +45 email@example.com|
|Principal Investigator:||Jonathan Vela||Dept. of rheumatology Aalborg University Hospital|